This study is a single-center, double blind, placebo-controlled, randomized, 2-arm, 2-sequence, crossover study
A planned sample size of 15 will be recruited into the study. This study will require one initial screening, one pre-study visit, two 6-hour study visits. The study will take 2-5 weeks per